Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$48,426
+$1,227 QoQ
Shares Held
309
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,433
of 1,603 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wellington Grp LLC holds $19,641,186 across 10 Drug Manufacturers - General names. NVS ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,159 | $14,583,870 | |
| 2 | MRK |
Merck & Co., Inc.
|
26,282 | $3,377,237 | |
| 3 | AMGN |
Amgen Inc
|
1,681 | $608,723 | |
| 4 | ABBV |
AbbVie Inc.
|
1,617 | $406,901 | |
| 5 | JNJ |
Johnson & Johnson
|
1,057 | $268,446 | |
| 6 | NVO |
Novo Nordisk A S
|
5,491 | $263,238 | |
| 7 | NVS |
Novartis AG
This page
|
309 | $48,426 | |
| 8 | AZN |
Astrazeneca PLC
|
225 | $42,664 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,426 | 309 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $47,199 | 309 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $78,723 | 571 | Shares | Sole | 2026-05-22 | |
| No filing history on record for this holder in this stock. | ||||||